PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot)
Sponsor: Canadian Critical Care Trials Group
This PHASE3 trial investigates Critically Ill and Deep Venous Thrombosis and is currently completed. Canadian Critical Care Trials Group leads this study, which shows 6 recorded versions since 2003 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Feb 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Canadian Critical Care Trials Group
- Canadian Institutes of Health Research (CIHR)
- Hamilton Health Sciences Corporation
For direct contact, visit the study record on ClinicalTrials.gov .